Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Department of Clinical Laboratory, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China; Shandong Engineering & Technology Research Center for Tumor Marker Detection, Jinan, China; Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory, Jinan, China.
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188490. doi: 10.1016/j.bbcan.2020.188490. Epub 2020 Dec 13.
Colorectal cancer (CRC) remains one of the most commonly diagnosed cancers and a leading cause of cancer-related deaths worldwide. The stepwise accumulation of epigenetic alterations in the normal colorectal epithelium has been reported to act as a driving force for the initiation and promotion of tumorigenesis in CRC. From a mechanistic standpoint, emerging evidence indicates that within the colorectal epithelium, the diverse gut microbiota can interact with host cells to regulate multiple physiological processes. In fact, recent studies have found that the gut microbiota represents a potential cause of carcinogenesis, invasion, and metastasis via DNA methylation, histone modifications, and non-coding RNAs - providing an epigenetic perspective for the connection between the gut microbiota and CRC. Herein, we comprehensively review the recent research that provides a comprehensive yet succinct evidence connecting the gut microbiota to CRC at an epigenetic level, including carcinogenic mechanisms of cancer-related microbiota, and the potential for utilizing the gut microbiota as CRC biomarkers. These scientific findings highlight a promising future for manipulating the gut microbiota to improve clinical outcomes in patients suffering from CRC.
结直肠癌(CRC)仍然是最常见的癌症之一,也是全球癌症相关死亡的主要原因。据报道,正常结直肠上皮中表观遗传改变的逐步积累是 CRC 发生和促进肿瘤发生的驱动力。从机制上讲,新出现的证据表明,在结直肠上皮内,多样化的肠道微生物群可以与宿主细胞相互作用,调节多种生理过程。事实上,最近的研究发现,肠道微生物群通过 DNA 甲基化、组蛋白修饰和非编码 RNA 代表了致癌、侵袭和转移的潜在原因——为肠道微生物群与 CRC 之间的联系提供了一个表观遗传学视角。在此,我们全面回顾了最近的研究,这些研究提供了全面而简洁的证据,将肠道微生物群与 CRC 在表观遗传水平上联系起来,包括与癌症相关的微生物群的致癌机制,以及将肠道微生物群用作 CRC 生物标志物的潜力。这些科学发现为操纵肠道微生物群以改善 CRC 患者的临床结果提供了一个充满希望的未来。